Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters.
In five patients with definite multiple sclerosis and lack of cell-mediated immunity to measles and parainfluenza virus antigens, various immunological parameters were studied before and during transfer factor treatment. The study showed that cell-mediated immunity to measles virus antigen, as evaluated by the leukocyte migration agarose test, could temporarily be restored, using repeated injections of transfer factor pooled from unselected, normal blood donors.
D000917:Antibody Formation; D000956:Antigens, Viral / Q000032:analysis; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008457:Measles / Q000276:immunology; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy*; D018184:Paramyxoviridae Infections / Q000276:immunology; D014165:Transfer Factor / Q000627:therapeutic use*
D000956:Antigens, Viral; D014165:Transfer Factor